Topic
Men's health
Evidence-based men's health, explained without marketing.
This page collects every article by Dr. Damon Tojjar in this topic. For all topics see browse by topic, and for the source-anchored record see damontojjar.com/record.
Articles in this topic (13)
- Blood Biomarkers After an Elevated PSA: What GOTEBORG-2 Showed for the 4Kscore
An elevated PSA is a starting point, not a diagnosis. In the GOTEBORG-2 prostate cancer screening trial, adding a 4Kscore blood test as a reflex step after an...
- Benign Prostate Enlargement: What the Medical-Therapy Evidence Supports
For benign prostate enlargement, the trial evidence draws a clean line between two goals: easing symptoms and changing the disease itself. Alpha-blockers relax...
- Evaluating Low-T Claims: How Testosterone Deficiency Is Actually Diagnosed in the Evidence
A defensible diagnosis of testosterone deficiency rests on two things held together, not one number in isolation. The 2018 Endocrine Society clinical practice...
- An Evidence-Based Preventive Checklist for Men: What the Guidelines Actually Support by Age
Only a handful of preventive screenings for men rest on strong evidence, and knowing which ones lets you spend a short appointment on what matters. The list with...
- Finasteride and the High-Grade Prostate Cancer Scare: A Detection-Bias Lesson
The short answerThe Prostate Cancer Prevention Trial (PCPT) produced two findings that looked like they were fighting each other. Finasteride, a 5-alpha reductase...
- Should an MRI Come Before the Prostate Biopsy? Reading the PRECISION Trial
The short answerPRECISION, a 500-man randomized trial published in the New England Journal of Medicine in 2018, tested whether doing an MRI before a prostate biopsy...
- Active Monitoring vs Surgery vs Radiotherapy: The 15-Year ProtecT Results
What the 15-year results actually showedAfter 15 years of follow-up, the ProtecT trial found that men with localized, PSA-detected prostate cancer died of their...
- PSA Screening: Why ERSPC and PLCO Point in Different Directions
The short answerTwo large randomized trials asked whether prostate-specific antigen (PSA) screening lowers the chance of dying from prostate cancer, and they...
- How to Read a Semen Analysis and the WHO Reference Limits
A reference limit is a percentile, not a verdictThe World Health Organization's 2021 sixth edition lower reference limits for semen analysis describe where the...
- The 2025 Testosterone Label Change, Explained: A Boxed Warning Dropped, a New One Added
In February 2025, the U.S. Food and Drug Administration made two class-wide changes to the labels of prescription testosterone products in the same action. It...
- How to Read the TRAVERSE Trial: What a Cardiovascular Safety Study Can and Cannot Tell You
The TRAVERSE trial asked one narrow question: in men with symptomatic hypogonadism who already had cardiovascular disease or were at high risk for it, does...
- Does Varicocele Repair Help Fertility? How the AUA/ASRM Evidence Reads
The short answerThe 2024 AUA/ASRM male-infertility guideline reads the varicocele evidence two ways, and that split is the whole story. For a man with a palpable...
- What Testosterone Does in the Body, and Why the Numbers Are Slippery
Testosterone is a signaling molecule, not a scoreboard. It circulates at levels that swing across the day, drift with age, and get read by laboratory assays that do...